Bridgewater Just Sold Salesforce: A Patient-Stock Debate
Bridgewater Associates exits its Salesforce stake, prompting a broader discussion on how patient capital should value...
Dividend aristocrats are companies that consistently increase their dividends for many years. Understanding them can improve your investment decisions.
4,918 articlesBridgewater Associates exits its Salesforce stake, prompting a broader discussion on how patient capital should value...
A veteran financial writer dives into a framework that aims to outpace the S&P over generations. Learn how Davis Fund...
Hollywood’s volatility isn’t just about red carpets. It reshapes how families plan money, time, and priorities. This ...
Alphabet's plan to issue new stock could dilute existing holders. This deep dive explains what that means for investo...
A high-profile insider sale at a growing regional bank has investors weighing motives and market signals. This guide ...
Two Nasdaq-100 trackers move in lockstep on performance, but their legal wrappers drive costs and tax implications. H...
Tech stocks retreat sparked a broader market pause, but analysts insist the stock market isn’t crashing — it’s a rota...
SpaceX is inching toward a public listing that could expose who truly owns private stakes and how that ownership tran...
Value stocks are delivering sharp gains in 2026 as earnings growth broadens beyond technology. Investors warn this fl...
As markets shift in mid-2026, investors seek a practical starting point for stock exposure. The article lays out star...
SpaceX's post-IPO moves could ripple through the market. This guide explains what to watch, how to react, and smart s...
When Congress tackles Social Security's funding challenges, the sting is felt far beyond retirees. This article break...